Denna sida på svenska

Per Stål

Associated

Visiting address : K 63, Karolinska Universitetssjukhuset Huddinge 141 86 Stockholm, Sweden
Postal address : Department of Medicine, Huddinge (MedH), H7, Unit for Gastroenterology and Rheumatology, K63, 141 86 Stockholm, Sweden
Delivery address : K63, 14186 Stockholm, Sweden

Publications

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, et al
Journal of hepatology 2017;67(6):1265-1273

Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease
Björkström K, Stål P, Hultcrantz R, Hagström H
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017;15(9):1461-1468

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
Dulai Ps, Singh S, Patel J, Soni M, Prokop Lj, Younossi Z, et al
Hepatology (Baltimore, Md.) 2017;65(5):1557-1565

In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma
Lilienberg E, Dubbelboer Ir, Karalli A, Axelsson R, Brismar Tb, Ebeling Barbier C, et al
Molecular pharmaceutics 2017;14(2):448-458

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease
Hagström H, Nasr P, Ekstedt M, Kechagias S, Önnerhag K, Nilsson E, et al
Scandinavian journal of gastroenterology 2017;52(2):159-165

Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma
Åström E, Stål P, Zenlander R, Edenvik P, Alexandersson C, Haglund M, et al
PloS one 2017;12(3):e0173897-

SAF score and mortality in NAFLD after up to 41 years of follow-up
Hagström H, Nasr P, Ekstedt M, Kechagias S, Stål P, Bedossa P, et al
Scandinavian journal of gastroenterology 2017;52(1):87-91

Statins and Angiotensin-Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease
Stokkeland K, Lageborn Ct, Ekbom A, Höijer J, Bottai M, Stål P, et al
Basic & clinical pharmacology & toxicology 2017;():-

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
Lykiardopoulos B, Hagström H, Fredrikson M, Ignatova S, Stål P, Hultcrantz R, et al
PloS one 2016;11(12):e0167776-

Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up
Hagström H, Nasr P, Bottai M, Ekstedt M, Kechagias S, Hultcrantz R, et al
Liver international : official journal of the International Association for the Study of the Liver 2016;36(11):1688-1695

[Not Available]
Stål P, Oksanen A
Lakartidningen 2016;113():-

[Not Available]
Stål P, Friis-liby I
Lakartidningen 2016;113():-

Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study
Hagström H, Stål P, Hultcrantz R, Hemmingsson T, Andreasson A
Journal of hepatology 2016;65(2):363-8

Reply
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al
Hepatology (Baltimore, Md.) 2016;64(1):310-1

Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P, Davidsdottir L, Oksanen A, Isaksson B, Hultcrantz R, Stål P
Liver international : official journal of the International Association for the Study of the Liver 2015;35(7):1862-71

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
Ekstedt M, Hagström H, Nasr P, Fredrikson M, Stål P, Kechagias S, et al
Hepatology (Baltimore, Md.) 2015;61(5):1547-54

FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity
Ahmed D, De Verdier Pj, Ryk C, Lunqe O, Stål P, Flygare J
Pharmacology research & perspectives 2015;3(5):e00171-

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study
Daniele B, Croitoru A, Papandreou C, Bronowicki Jp, Mathurin P, Serejo F, et al
Future oncology (London, England) 2015;11(18):2553-62

Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance
Stål P
World journal of gastroenterology 2015;21(39):11077-87

Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis
Fischer Ma, Kartalis N, Grigoriadis A, Loizou L, Stål P, Leidner B, et al
European radiology 2015;25(11):3123-32

Validation of a competitive ELISA assay for the quantification of human serum hepcidin
Dahlfors G, Stål P, Hansson Ec, Bàràny P, Sisowath C, Onelöv L, et al
Scandinavian journal of clinical and laboratory investigation 2015;75(8):652-8

Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis
Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Österreicher C, et al
Human molecular genetics 2014;23(14):3883-90

Expression of thioredoxins and glutaredoxins in human hepatocellular carcinoma: correlation to cell proliferation, tumor size and metabolic syndrome
Mollbrink A, Jawad R, Vlamis-gardikas A, Edenvik P, Isaksson B, Danielsson O, et al
International journal of immunopathology and pharmacology 2014;27(2):169-83

A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis
Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, Rose N, et al
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;57(2):230-6

Sorafenib prolongs liver regeneration after hepatic resection in rats
Mollbrink A, Augsten M, Hultcrantz R, Eriksson Lc, Stål P
The Journal of surgical research 2013;184(2):847-54

Alcohol consumption in patients with primary sclerosing cholangitis
Hagström H, Stål P, Stokkeland K, Bergquist A
World journal of gastroenterology 2012;18(24):3105-11

[Hereditary hemochromatosis--a common genetic disease]
Stål P, Hultcrantz R
Lakartidningen 2012;109(46):2097-9

Iron-regulatory gene expression during liver regeneration
Mollbrink A, Holmstrom P, Sjostrom M, Hultcrantz R, Eriksson Lc, Stal P
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2012;47(5):591-600

Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study
Elmberg M, Hultcrantz R, Simard Jf, Stål P, Pehrsson K, Askling J
Journal of internal medicine 2012;272(1):45-54

Attenuated liver fibrosis after bile duct ligation and defective hepatic stellate cell activation in neural cell adhesion molecule knockout mice
Rosenberg P, Sjostrom M, Soderberg C, Kinnman N, Stal P, Hultcrantz R
LIVER INTERNATIONAL 2011;31(5):630-41

Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics
Wahlin S, Floderus Y, Stal P, Harper P
JOURNAL OF INTERNAL MEDICINE 2011;269(3):278-88

Health check-ups and family screening allow detection of hereditary hemochromatosis with less advanced liver fibrosis and survival comparable with the general population
Aleman S, Endalib S, Stal P, Loof L, Lindgren S, Sandberg-gertzen H, et al
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2011;46(9):1118-26

[Life-saving transplantation in pregnancy-related liver failure. Well functioning care continuity contributed to the good result]
Agren A, Stål P, Agvald-ohman C, Eleborg L, Nowak G, Ajne G
Lakartidningen 2011;108(3):92-5

Liver Transplantation for Erythropoietic Protoporphyria in Europe
European Liver Intestine Transplan, Wahlin S, Stal P, Adam R, Karam V, Porte R, et al
LIVER TRANSPLANTATION 2011;17(9):1021-6

Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis
Soderberg C, Marmur J, Eckes K, Glaumann H, Sallberg M, Frelin L, et al
APMIS 2011;119(7):412-20

Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn's disease
Stal P, Befrits R, Ronnblom A, Danielsson A, Suhr O, Stahlberg D, et al
ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2010;31(3):387-95

Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al
HEPATOLOGY 2010;51(2):595-602

DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas
Jonsson C, Stal P, Sjoqvist U, Akerlund Je, Lofberg R, Moller L
MUTAGENESIS 2010;25(5):499-504

FIRST INTERIM RESULTS OF THE GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB (GIDEON) STUDY
Lencioni R, Lim Hy, Stal P, Marrero Ja, Kudo M, Venook Ap, et al
ANNALS OF ONCOLOGY 2010;:258-259

Liver transplantation of patients with cryptogenic cirrhosis: Clinical characteristics and outcome
Marmur J, Bergquist A, Stal P
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2010;45(1):60-9

SORAFENIB TREATMENT AND SAFETY PROFILE IN CHILD PUGH B PATIENTS CHARACTERIZED IN FIRST INTERIM RESULTS OF GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB)
Marrero Ja, Lim Hy, Stal P, Lencioni R, Kudo M, Venook A, et al
HEPATOLOGY 2010;52(4):1140A-1140A

A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)
Gafvels M, Holmstrom P, Somell A, Sjovall F, Svensson Jo, Stahle L, et al
LIVER INTERNATIONAL 2009;29(7):1116-24

[Elastography--a new tool for diagnosis of chronic liver diseases. Might replace liver biopsy, but not always]
Stål P, Von Seth E, Bergquist A, Nemeth A, Weiland O
Lakartidningen 2009;106(50-51):3412-4

Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives
Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Loof L, et al
GASTROENTEROLOGY 2009;137(4):1301-9

[Disturbed iron balance in hemochromatosis and inflammation. Discovery of iron-regulating hormone hepcidin gives new explanations]
Stål P, Gåfvels M, Eggertsen G, Holmström P
Lakartidningen 2007;104(22):1696-700

[Transformation of microscopic colitis to inflammatory bowel disease]
Janczewska I, Stål P, Sandstedt B
Lakartidningen 2007;104(20-21):1597-8

Expression of iron regulatory genes in a rat model of hepatocellular carcinoma
Holmstrom P, Gafvels M, Eriksson Lc, Dzikaite V, Hultcrantz R, Eggertsen G, et al
LIVER INTERNATIONAL 2006;26(8):976-85

Regulatory effects of tumor necrosis factor-alpha and interleukin-6 on HAMP expression in iron loaded rat hepatocytes
Dzikaite V, Holmstrom P, Stal P, Eckes K, Hagen K, Eggertsen G, et al
JOURNAL OF HEPATOLOGY 2006;44(3):544-51

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, et al
GASTROENTEROLOGY 2003;125(6):1733-41

Structure and liver cell expression pattern of the HFE gene in the rat
Holmstrom P, Dzikaite V, Hultcrantz R, Melefors O, Eckes K, Stal P, et al
JOURNAL OF HEPATOLOGY 2003;39(3):308-14

Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls
Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P
GUT 2002;51(5):723-30

Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma
Bergquist A, Glaumann H, Stal P, Wang Gs, Broome U
JOURNAL OF INTERNAL MEDICINE 2001;249(1):69-75

Diet restriction increases ubiquinone contents and inhibits progression of hepatocellular carcinoma in the rat
Wang Gs, Olsson Jm, Eriksson Lc, Stal P
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2000;35(1):83-9

Phlebotomy increases cadmium uptake in hemochromatosis
Akesson A, Stal P, Vahter M
ENVIRONMENTAL HEALTH PERSPECTIVES 2000;108(4):289-91

Dietary iron overload inhibits carbon tetrachloride induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation
Wang Gs, Eriksson Lc, Xia L, Olsson J, Stal P
JOURNAL OF HEPATOLOGY 1999;30(4):689-98

Effects of dietary iron overload on progression in chemical hepatocarcinogenesis
Stal P, Wang Gs, Olsson Jm, Eriksson Lc
LIVER 1999;19(4):326-34

Gastroesophageal reflux in healthy subjects - Significance of endoscopic findings, histology, age, and sex
Stal P, Lindberg G, Ost A, Iwarzon M, Seensalu R
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 1999;34(2):121-8

Quantitative determination of 8-hydroxy-2 '-deoxyguanosine in human urine by isotope dilution mass spectrometry: Normal levels in hemochromatosis
Holmberg I, Stal P, Hamberg M
FREE RADICAL BIOLOGY AND MEDICINE 1999;26(1-2):129-35

Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis
Eliasson E, Stal P, Oksanen A, Lytton S
JOURNAL OF HEPATOLOGY 1998;29(5):819-25

HFE mutations in patients with hereditary haemochromatosis in Sweden
Cardoso Emp, Stal P, Hagen K, Cabeda Jm, Esin S, De Sousa M, et al
JOURNAL OF INTERNAL MEDICINE 1998;243(3):203-8

Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis
Stal P, Olsson J, Svoboda P, Hultcrantz R, Harmsringdahl M, Eriksson Lc
JOURNAL OF HEPATOLOGY 1997;27(3):562-71

Hepatotoxicity induced by iron overload and alcohol - Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation
Stal P, Johansson I, Ingelmansundberg M, Hagen K, Hultcrantz R
JOURNAL OF HEPATOLOGY 1996;25(4):538-46

INCREASED PIZ GENE-FREQUENCY FOR ALPHA(1) ANTITRYPSIN IN PATIENTS WITH GENETIC HEMOCHROMATOSIS
Elzouki Any, Hultcrantz R, Stal P, Befrits R, Eriksson S
GUT 1995;36(6):922-6

IRAN AS A HEPATOTOXIN
Stal P
DIGESTIVE DISEASES 1995;13(4):205-22

KUPFFER CELL IRON OVERLOAD INDUCES INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION ON HEPATOCYTES IN GENETIC HEMOCHROMATOSIS
Stal P, Broome U, Scheynius A, Befrits R, Hultcrantz R
HEPATOLOGY 1995;21(5):1308-16

THE EFFECTS OF DIETARY IRON ON INITIATION AND PROMOTION IN CHEMICAL HEPATOCARCINOGENESIS
Stal P, Hultcrantz R, Moller L, Eriksson Lc
HEPATOLOGY 1995;21(2):521-8

Show all publications